Why Your Supplier Is Asking for a TSE/BSE Certificate (And Why You Should Care)

If you work in pharmaceutical procurement or quality, you've seen the email. Your supplier wants a signed declaration confirming your product is free from transmissible spongiform encephalopathy agents. Maybe it's a chemical you manufacture. Maybe it's an excipient. Maybe it's something that has never been anywhere near a cow.

You might be tempted to file it under "regulatory theater" and move on. Don't.

That certificate is the end of a chain that starts with a disease that terrified governments, destroyed an industry, and changed how the world thinks about pharmaceutical safety. Understanding why it exists will tell you when you actually need one, when you don't, and how to respond without wasting your time or your supplier's.

The Disease That Broke the Rules

Transmissible spongiform encephalopathies are not like other infectious diseases. They're caused by prions, misfolded proteins that have no DNA or RNA . They don't respond to antibiotics. They don't trigger an immune response. They can't be killed by standard sterilization.

The first documented case was scrapie in sheep, described in the 1700s . For two centuries, it was a curiosity among shepherds. The affected animals would scrape their fleece against fences and rocks, hence the name. It didn't seem to affect other livestock or humans.

That changed in the 1980s. British cattle started showing similar symptoms. The disease was called bovine spongiform encephalopathy. The press called it mad cow disease. By the time the epidemic peaked in 1992, over 180,000 cattle in the UK had been infected .

The cause was traced to a practice that made perfect economic sense at the time. Farmers had been feeding cattle meat-and-bone meal, a protein supplement made from rendered sheep and cattle remains . Scrapie prions from sheep survived the rendering process. They crossed the species barrier into cattle.

That species barrier turned out to be lower than anyone thought.

The Human Toll

In 1996, the UK reported a new disease in humans. Variant Creutzfeldt-Jakob disease. It affected younger people than classical CJD, with different symptoms and different brain pathology .

The link to BSE was confirmed through strain typing. The prion that caused mad cow disease was the same one causing vCJD in humans who had eaten contaminated beef products .

By 2012, 176 cases of vCJD had been reported in Britain alone . Cases appeared in France, Ireland, Italy, the US, Canada, Japan, and elsewhere. Some were linked to blood transfusions from infected donors. The UK spent over £200 million on measures to protect surgical instruments from prion contamination .

The disease has an incubation period measured in years or decades. There is no treatment. There is no cure.

Why This Matters for Pharmaceuticals

You might wonder what any of this has to do with a chemical supplier.

Pharmaceuticals use animal-derived materials in ways most people never see. Gelatin capsules come from bovine and porcine collagen. Some vaccines are grown in media containing bovine serum. Heparin comes from pig intestines. Even certain excipients and reagents use animal-derived ingredients during manufacturing .

Regulators faced a problem. They couldn't simply ban all animal-derived materials. Some are essential. But they couldn't ignore the risk either.

The solution was a risk-based framework. The European Medicines Agency published guidance on minimizing TSE transmission through medicinal products . The core principle is simple. Manufacturers must demonstrate that their materials either don't come from TSE-relevant species, or that the sourcing and processing steps reduce the risk to acceptable levels.

This is where the TSE/BSE certificate comes in. It's a supplier's written statement that their product either contains no animal-derived materials or that any animal-derived materials meet the regulatory requirements.

The Counterintuitive Part: Why Synthetic Chemicals Need Certificates

Here's where most people get confused. Your product might be entirely synthetic. It might be produced from petroleum feedstock. It might never have touched a cow, a sheep, or any living creature.

Why would anyone ask for a TSE/BSE certificate?

The answer is contamination. Not of your product, but of your manufacturing process.

The EMA guidance requires assessment of "starting materials, raw materials, and reagents" used in production . A supplier questionnaire from a major pharmaceutical company asks whether equipment is "in contact at any time with other materials of animal origin" . It asks whether chromatography media or buffers contain animal-derived components. It asks whether the product is stored or transported alongside animal-derived materials.

A synthetic chemical produced in a facility that also handles bovine-derived products carries a theoretical risk. A reagent filtered through a membrane that was validated using animal-derived proteins carries a theoretical risk. The prion is remarkably stable. It adheres tenaciously to surfaces and resists standard decontamination .

The certificate is a statement about your entire supply chain, not just your molecule.

When a Certificate Is Not Required

Not every product needs a TSE/BSE declaration. The framework has boundaries.

The European Pharmacopoeia general monograph applies to products that contain or use materials from TSE-relevant species in their manufacture. If your product is entirely synthetic, never contacts animal-derived materials, and isn't processed on shared equipment with such materials, you're outside the scope.

Several companies publish declarations stating exactly this. Fisher Scientific's certificate for certain products states that the "products are manufactured completely from synthetic or manufactured materials and do not contain any raw materials produced from, or substances derived from animal origin". BioSpectra's statement for Tris Hydrochloride declares it "a synthetic chemical" with no animal-derived raw materials.

These declarations exist because customers ask for them. They're not required by regulation for every product. They're a convenience, a standardized way to answer the question that every pharmaceutical quality department must ask.

The confusion arises because some companies issue TSE/BSE certificates for everything, creating the impression that everything needs one. It doesn't. If you're supplying a purified inorganic salt produced from mined minerals, there's no regulatory requirement for a TSE certificate. But your customer may still ask, because their internal procedures don't distinguish between categories.

How to Read a TSE/BSE Certificate

Not all certificates are equal. Some are simple affirmations. Others contain specific claims about sourcing, processing, and traceability.

The strongest certificates provide specific information: the species of origin for any animal-derived materials, the country of origin, the tissues used, and the steps taken to reduce TSE risk . They may reference the EMA guideline by name and confirm that the product falls outside its scope.

The weakest certificates are vague. They say the product is "TSE/BSE free" without explaining what that means or how the conclusion was reached.

A useful distinction is between a supplier declaration and an EDQM Certificate of Suitability. The European Directorate for the Quality of Medicines issues TSE Certificates of Suitability for certain starting materials, particularly those of bovine origin used in pharmaceutical manufacturing . These certificates involve regulatory review of the supplier's risk assessment. They carry more weight than a self-declared statement.

If your customer accepts a simple declaration, that's their choice. If they require an EDQM certificate, you're in a different category of product.

What This Means for You

If you're a supplier being asked for a TSE/BSE certificate, the first question is whether your product actually falls within scope. If it's synthetic and never contacts animal-derived materials, you can issue a simple declaration stating that fact. Many companies have template language for this.

If your product does involve animal-derived materials, the answer is more complex. You need to know the species, the tissue, the country of origin, and the processing steps. You need to assess whether those steps reduce TSE risk. You need to document it.

If you're a pharmaceutical manufacturer receiving certificates, don't treat them as checkboxes. The certificate is a claim about the supply chain. If the claim is vague, ask for specifics. If the supplier can't provide specifics, that's information too.

The mad cow epidemic is largely contained. The regulatory framework it created is here to stay. The certificate you're asked to sign is a small part of a system designed to prevent a disease that has no cure from entering the pharmaceutical supply chain.

It's worth taking seriously.